Bispecific antibodies are a specialized group of hazardous drugs that can elicit dramatic host reactions such as cytokine release syndrome (CRS) and related immune effector cell-associated neurotoxicity syndrome (ICANS) requiring monitoring, prompt recognition, and an advanced level of intervention.
To learn more, see: Bispecific Antibodies.
